MRCP+
PerspectumProduct specifications |
Information source:
Public
Last updated: Jan. 27, 2020 |
General | |
---|---|
Product name | MRCP+ |
Company | Perspectum |
Subspeciality | Abdomen |
Modality | MR |
Disease targeted | Primary sclerosing cholangitis (PSC), Primary biliary cholangitis (PBC), and Biliary Atresia, liver transplantation |
Key-features | Biliary system segmentation, width and volume quantification |
Suggested use | |
Data characteristics | |
Population | |
Input | Magnetic resonance cholangiopancreatography (MRCP) |
Input format | |
Output | |
Output format | |
Technology | |
Integration | |
Deployment | |
Trigger for analysis | |
Processing time | |
Certification | |
CE
|
Certified,
Class unknown
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 01-2019 |
Distribution channels | Nuance PIN, Calantic |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | |
Based on | |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |